The Role of Older Pharmacological Therapies in Cardiovascular Disease

Moderator:

Discussants:

  • Summary:

    Dr. Henry Black from The New York University School of Medicine moderated the topic "The Role of Older Pharmacological Therapies in Cardiovascular Disease," with Drs. William Cushman from the University of Tennessee College of Medicine, William Frishman from the New York Medical College, and Domenic Sica from Virginia Commonwealth University participating.

    The discussion focused primarily on:
    (1) The comparison of efficacy, cost and side effect profiles of the older cardiovascular drugs versus the newer compounds,
    (2) the use of beta blockers, diuretics, calcium channel blockers, anticoagulants, aldosterone receptor antagonists, angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs) and anti-anginals in the treatment of cardiovascular disease,
    (3) the use of beta blockers in hypertensive patients,
    (4) the use of aldosterone receptor antagonists in the treatment of resistant hypertensives,
    (5) the use of ACE inhibitors and ARBs in patients taking aldosterone receptor antagonists,
    (6) the use of reserpine as an older but effective antihypertensive,
    (7) a comparison of the nticoagulants warfarin and dabigatran, and
    (8) the use of appropriate diuretic therapy.
    (Med Roundtable Cardiovasc Ed. 2011;2(2):82-90) ©2011 FoxP2 Media, LLC

You are not authorized to access this content.

You are not authorized to access this content.
You are not authorized to access this content.
Please subscribe to use our print features or to download PDF files.